| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Truist Securities analyst Richard Newitter reiterates Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price...
UBS analyst Danielle Antalffy maintains Treace Medical Concepts (NASDAQ:TMCI) with a Neutral and lowers the price target fro...
JP Morgan analyst Lilia-Celine Lozada downgrades Treace Medical Concepts (NASDAQ:TMCI) from Neutral to Underweight and lower...
BTIG analyst Ryan Zimmerman downgrades Treace Medical Concepts (NASDAQ:TMCI) from Buy to Neutral.